OBJECTIVES: To analyse the frequency and predictors of new-onset cardiovascular (CV) risk factors in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) and giant cell arteritis (GCA). METHODS: We analysed the frequency and predictors of new-onset hypertension and/or diabetes mellitus (HTN/DM) amongst patients with AAV or GCA recruited in the Diagnostic and Classification of Vasculitis (DCVAS) study. Patients with pre-existing HTN/DM were excluded. RESULTS: We included 873 patients with AAV (506 GPA, 183 MPA, 184 EGPA), and 443 with GCA. Patients with GCA were more likely female (68% vs. 52%; p<0.001) and older (71.33±8.65 vs. 52.80±16.48; p<0.001) compared to patients with AAV. HTN/DM developed within 6 mont...
Objective. To evaluate the risk of cerebrovascular disease and cardiovascular disease (CVD) in patie...
OBJECTIVE: To determine the incidence of arterial thrombotic events (ATE) and venous thromboembolism...
OBJECTIVE: To determine the incidence of arterial thrombotic events (ATE) and venous thromboembolism...
OBJECTIVE: To explore the risk of cardiovascular disease in patients with antineutrophil cytoplasmic...
International audienceDespite improvement in the prognosis of ANCA-associated vasculitides (AAVs), i...
Objective: We investigated the prevalence of metabolic syndrome (MetS) in all or nonobese patients w...
Objectives: Patients with ANCA-associated vasculitis are at increased risk of cardiovascular events....
AbstractGiant Cell Arteritis (GCA) is the most common vasculitis in adults among people in the weste...
Objectives: Several chronic inflammatory diseases are associated with cardiovascular disease, but th...
OBJECTIVES: ANCA-associated vasculitis (AAV) can affect all age groups. We aimed to show that differ...
Objective: to evaluate the risk of cerebrovascular disease and cardiovascular disease (CVD) in patie...
Objectives: To determine the incidence rate (IR) and predictors of acute myocardial infarction (MI) ...
International audienceBackground/Purpose: The risk of cardiovascular events (CVE) during giant cell ...
International audienceTo assess the cardiovascular disease (CVD) and venous thromboembolism (VTE) ri...
Background: Cardiovascular diseases (CVD) are the major causes of death in antineutrophil cytoplasmi...
Objective. To evaluate the risk of cerebrovascular disease and cardiovascular disease (CVD) in patie...
OBJECTIVE: To determine the incidence of arterial thrombotic events (ATE) and venous thromboembolism...
OBJECTIVE: To determine the incidence of arterial thrombotic events (ATE) and venous thromboembolism...
OBJECTIVE: To explore the risk of cardiovascular disease in patients with antineutrophil cytoplasmic...
International audienceDespite improvement in the prognosis of ANCA-associated vasculitides (AAVs), i...
Objective: We investigated the prevalence of metabolic syndrome (MetS) in all or nonobese patients w...
Objectives: Patients with ANCA-associated vasculitis are at increased risk of cardiovascular events....
AbstractGiant Cell Arteritis (GCA) is the most common vasculitis in adults among people in the weste...
Objectives: Several chronic inflammatory diseases are associated with cardiovascular disease, but th...
OBJECTIVES: ANCA-associated vasculitis (AAV) can affect all age groups. We aimed to show that differ...
Objective: to evaluate the risk of cerebrovascular disease and cardiovascular disease (CVD) in patie...
Objectives: To determine the incidence rate (IR) and predictors of acute myocardial infarction (MI) ...
International audienceBackground/Purpose: The risk of cardiovascular events (CVE) during giant cell ...
International audienceTo assess the cardiovascular disease (CVD) and venous thromboembolism (VTE) ri...
Background: Cardiovascular diseases (CVD) are the major causes of death in antineutrophil cytoplasmi...
Objective. To evaluate the risk of cerebrovascular disease and cardiovascular disease (CVD) in patie...
OBJECTIVE: To determine the incidence of arterial thrombotic events (ATE) and venous thromboembolism...
OBJECTIVE: To determine the incidence of arterial thrombotic events (ATE) and venous thromboembolism...